ArticleWorld journal of gastrointestinal oncology2019

Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study.

Valeria Basso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.